Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
10 Years Aggregate
CFO
$27,103.00 Mln
EBITDA
$36,860.00 Mln
Net Profit
$10,939.00 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Becton Dickinson and Company (BDXB)
| -3.8 | -4.7 | -0.7 | -6.1 | 15.3 | -- | -- |
|
BSE Sensex*
| -11.7 | -4.8 | 1.7 | -7.5 | 3.9 | 5.1 | 9.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Becton Dickinson and Company (BDXB)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical... industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey. Read more
-
Pres, CEO & Chairman
Mr. Thomas E. Polen Jr.
-
Exec. VP & CFO
Mr. Christopher DelOrefice
-
Headquarters
Franklin Lakes, NJ
-
Website
FAQs for Becton Dickinson and Company (BDXB)
What is the current share price of Becton Dickinson and Company (BDXB) Today?
The share price of Becton Dickinson and Company (BDXB) is $48.16 (NYSE) as of 31-May-2023 19:00 EDT. Becton Dickinson and Company (BDXB) has given a return of 15.28% in the last 3 years.
What is the current PB & PE ratio of Becton Dickinson and Company (BDXB)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
7.59 |
0.53 |
2021 |
7.64 |
0.68 |
2020 |
18.13 |
0.67 |
2019 |
-- |
-- |
2018 |
-- |
-- |
What is the 52 Week High and Low of Becton Dickinson and Company (BDXB)?
The 52-week high and low of Becton Dickinson and Company (BDXB) are Rs -- and Rs -- as of 10-Sep-2026.
What is the market cap of Becton Dickinson and Company (BDXB)?
Becton Dickinson and Company (BDXB) has a market capitalisation of -- as on 31-May-2023. As per SEBI classification, it is a company.
Should I invest in Becton Dickinson and Company (BDXB)?
Before investing in Becton Dickinson and Company (BDXB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.